• C02AC01 Clonidine 1 drugs
• C02AC02 Guanfacine 11 drugs
• C02AC05 Moxonidine 3 drugs

Drugs with code C02AC

• CATAPRESAN 0.150 MG TABLETS

  Form: tablets

  Active substance	Dosage
  clonidine hydrochloride	0,150 mg

  ATC code: C02A, C02AC, C02AC01

  Manufacturer: Glenwood Gmbh Pharmazeutische Erzeugnisse

• INTUNIV 1 MG PROLONGED-RELEASE TABLETS

  Form: tablets, prolonged-release

  Active substance	Dosage
  guanfacine hydrochloride	1,14 mg

  ATC code: C02A, C02AC, C02AC02

  Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch

• INTUNIV 2 MG PROLONGED-RELEASE TABLETS

  Form: tablets, prolonged-release

  Active substance	Dosage
  guanfacine hydrochloride	2,28 mg

  ATC code: C02A, C02AC, C02AC02

  Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch

• INTUNIV 3 MG PROLONGED-RELEASE TABLETS

  Form: tablets, prolonged-release

  Active substance	Dosage
  guanfacine hydrochloride	3,42 mg

  ATC code: C02A, C02AC, C02AC02

  Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch

• INTUNIV 4 MG PROLONGED-RELEASE TABLETS

  Form: tablets, prolonged-release

  Active substance	Dosage
  guanfacine hydrochloride	4,56 mg

  ATC code: C02A, C02AC, C02AC02

  Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch

• MOXON 0.2 MG FILM-COATED TABLETS

  Form: tablets, film-coated

  Active substance	Dosage
  moxonidine	0,2 mg

  ATC code: C02A, C02AC, C02AC05

  Manufacturer: Viatris Healthcare Limited

• MOXON 0.3 MG FILM-COATED TABLETS

  Form: tablets, film-coated

  Active substance	Dosage
  moxonidine	0,3 mg

  ATC code: C02A, C02AC, C02AC05

  Manufacturer: Viatris Healthcare Limited

• MOXON 0.4 MG FILM-COATED TABLETS

  Form: tablets, film-coated

  Active substance	Dosage
  moxonidine	0,4 mg

  ATC code: C02A, C02AC, C02AC05

  Manufacturer: Viatris Healthcare Limited

• PAXNEURY 1 MG PROLONGED-RELEASE TABLETS EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  guanfacine hydrochloride	1,148 mg

  ATC code: C02A, C02AC, C02AC02

  Manufacturer: Neuraxpharm Pharmaceuticals S.L.

• PAXNEURY 2 MG PROLONGED-RELEASE TABLETS EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  guanfacine hydrochloride	2,296 mg

  ATC code: C02A, C02AC, C02AC02

  Manufacturer: Neuraxpharm Pharmaceuticals S.L.

• PAXNEURY 3 MG PROLONGED-RELEASE TABLETS EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  guanfacine hydrochloride	3,444 mg

  ATC code: C02A, C02AC, C02AC02

  Manufacturer: Neuraxpharm Pharmaceuticals S.L.

• PAXNEURY 4 MG PROLONGED-RELEASE TABLETS EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  guanfacine hydrochloride	4,592 mg

  ATC code: C02A, C02AC, C02AC02

  Manufacturer: Neuraxpharm Pharmaceuticals S.L.

• PAXNEURY 5 MG PROLONGED-RELEASE TABLETS

  Form: tablets, prolonged-release

  Active substance	Dosage
  guanfacine hydrochloride	5,740 mg

  ATC code: C02A, C02AC, C02AC02

  Manufacturer: Neuraxpharm Pharmaceuticals S.L.

• PAXNEURY 6 MG PROLONGED-RELEASE TABLETS

  Form: tablets, prolonged-release

  Active substance	Dosage
  guanfacine hydrochloride	6,88 mg

  ATC code: C02A, C02AC, C02AC02

  Manufacturer: Neuraxpharm Pharmaceuticals S.L.

• PAXNEURY 7 MG PROLONGED-RELEASE TABLETS

  Form: tablets, prolonged-release

  Active substance	Dosage
  guanfacine hydrochloride	8,036 mg

  ATC code: C02A, C02AC, C02AC02

  Manufacturer: Neuraxpharm Pharmaceuticals S.L.